Astrazeneca Wins Dismissal of Verus’s Lawsuit Over Children’s Asthma Drug – Bloomberg

Astrazeneca Wins Dismissal of Verus's Lawsuit Over Children's Asthma Drug
Bloomberg
The London-based drugmaker agreed in 2007 to pay more than $310 million to Verus for its pediatric asthma-medicines program. Under the deal, Verus got $30

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *